Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  Nektar Therapeutics completes target enrollment in REZOLVE-AD phase 2b trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis,   January 13, 2025
  Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia,   January 13, 2025
  ProMIS Neurosciences begins PRECISE-AD phase 1b trial of lead therapeutic candidate, PMN310 in Alzheimer’s disease,   January 13, 2025
  Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer,   January 13, 2025
  Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging,   January 13, 2025
  CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis,   January 11, 2025
  Bayer announces elinzanetant meets all primary and secondary endpoints in phase III study OASIS 4 to treat moderate to severe VMS caused by breast cancer,   January 11, 2025
  Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension,   January 10, 2025
  IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial,   January 10, 2025
  Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor,   January 10, 2025
  Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma,   January 10, 2025
  ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck,   January 09, 2025
  Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours,   January 08, 2025
  US FDA issues draft guidance on including tissue biopsies in clinical trials,   January 08, 2025
  Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency,   January 08, 2025
  Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection,   January 07, 2025
  SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2 clinical trials on innovative Gamma Delta T-cell cancer therapy in India,   January 07, 2025
  Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints,   January 07, 2025
  Chime Biologics & Mabgeek achieve MG-K10 PPQ milestone, advancing AD and asthma therapies antibody drug MG-K10 late-stage clinical trials and commercialization,   January 06, 2025
  Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours,   January 04, 2025

  • Results Found: 15947
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 798
 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram